Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 3 4Phase 2 4Phase 4 1Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 4690INDUSTRY 2362NIH 888NETWORK 287FED 9UNKNOWN 4OTHER_GOV 4INDIV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 2Head & Neck 1Breast 1

Conditions

Sarcoma, Kaposi 2Squamous Cell Carcinoma of Head and Neck 1Immune Reconstitution Inflammatory Syndrome 1Breast Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Valganciclovir 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Has results × Clear all
NCT03755141 2025-07-22

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

National Cancer Center, Korea

Phase 2 Completed
109 enrolled 7 charts
Breast

Breast Neoplasms

NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

National Institute of Cancerología

Phase 2 Completed
40 enrolled 6 charts
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

NCT01774760 2019-10-04

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

Turku University Hospital

Phase 2 Completed
10 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01296815 2015-07-27

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Centro de Investigación en. Enfermedades Infecciosas, Mexico

Phase 2 Completed
14 enrolled 7 charts
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡